Feature|Videos|December 1, 2025

The Benefits of Nattokinase with NSK-SD®

Key Takeaways

  • Understand the research and rigorous testing that support the quality and identity of NSK-SD®.
  • Learn how NSK-SD® may play a role in supporting women’s cardiovascular health.
SHOW MORE

Vincent Hackel, President & CEO of JBSL-USA, shares how NSK-SD® sets the standard in nattokinase science—from research and manufacturing to global opportunities in women’s heart-health innovation.

Sponsored by JBSL-USA

In this interview, Vincent Hackel, President and CEO of JBSL-USA, explores the science and innovation behind NSK-SD®, a nattokinase enzyme derived from non-GMO soybeans and backed by a growing body of clinical research. He explains how JBSL’s proprietary manufacturing process and decades of study distinguish NSK-SD® from other nattokinase ingredients. Hackel also touches on the enzyme’s potential relevance to cardiovascular wellness—including women’s heart health—along with opportunities for product developers to incorporate NSK-SD® into retail formulations. He concludes with a look at the global regulatory landscape and the expanding international demand for clinically supported cardiovascular ingredients.


Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.